The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Multisystem immune-related adverse events from anti-PD-1/PD-L1 in patients with lung cancer: Incidence, clinical patterns, management, and outcomes.
 
Bairavi Shankar
No Relationships to Disclose
 
Jiajia Zhang
No Relationships to Disclose
 
Durrant Barasa
No Relationships to Disclose
 
Patrick M. Forde
Consulting or Advisory Role - AstraZeneca/MedImmune; Boehringer Ingelheim; Celgene
Research Funding - AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Kyowa Hakko Kirin (Inst); Novartis (Inst)
 
Josephine Louella Feliciano
Consulting or Advisory Role - AstraZeneca; Genentech; Merck; Pfizer
Research Funding - genentech; Merck
 
Kristen Marrone
Honoraria - Cardinal Health
 
Ronan Joseph Kelly
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Cardinal Health; Clovis Oncology; EMD Serono; Gritstone Bio; Lilly; Novartis; OncoMed
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst)
 
David S. Ettinger
Consulting or Advisory Role - BeyondSpring Pharmaceuticals; Boehringer Ingelheim; Bristol-Myers Squibb; Genentech; Golden Biotechnology; Guardant Health; Lilly
 
Christine L. Hann
Consulting or Advisory Role - Abbvie; Ascentage Pharma; Ascentage Pharma; Bristol-Myers Squibb; Genentech/Roche
Research Funding - Abbvie (Inst); Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); GlaxoSmithKline (Inst); Merrimack (Inst)
 
Julie R. Brahmer
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Genentech; Janssen Oncology; Lilly; Merck; Syndax
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Incyte (Inst); Janssen Oncology (Inst); Merck (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck
Other Relationship - Bristol-Myers Squibb; merck
 
Jarushka Naidoo
Honoraria - AstraZeneca/MedImmune; Bristol-Myers Squibb
Consulting or Advisory Role - AstraZeneca/MedImmune; Bristol-Myers Squibb; Takeda
Research Funding - AstraZeneca (Inst); Calithera Biosciences (Inst); Kyowa Hakko Kirin (Inst); Merck (Inst)
Travel, Accommodations, Expenses - AstraZeneca/MedImmune; Bristol-Myers Squibb